HomeBVS • NASDAQ
add
Bioventus Inc
Previous close
$6.54
Day range
$6.51 - $6.96
Year range
$5.28 - $14.37
Market cap
557.76M USD
Avg Volume
475.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 123.88M | -4.31% |
Operating expense | 78.08M | -6.10% |
Net income | -2.64M | 46.07% |
Net profit margin | -2.13 | 43.65% |
Earnings per share | 0.08 | 14.29% |
EBITDA | 16.84M | -1.00% |
Effective tax rate | 2.78% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.80M | -9.42% |
Total assets | 691.41M | -12.95% |
Total liabilities | 505.94M | -12.29% |
Total equity | 185.48M | — |
Shares outstanding | 66.36M | — |
Price to book | 2.92 | — |
Return on assets | 1.75% | — |
Return on capital | 2.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.64M | 46.07% |
Cash from operations | -19.33M | -221.92% |
Cash from investing | -826.00K | 17.40% |
Cash from financing | 947.00K | 122.32% |
Net change in cash | -18.78M | -59.27% |
Free cash flow | -26.76M | -189.39% |
About
Founded
2011
Website
Employees
930
